Why ARVN? Arvinas, Inc. Analysis, Price & AI Insights | Whystock
ARVN
$10.51+0.61 (+6.16%)
Market ClosedLast close May 1
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.